JW (Cayman) Therapeutics Co. Ltd

JWCTF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$591-$768-$846-$702
Dep. & Amort.$90$100$81$46
Deferred Tax$0$0-$68-$61
Stock-Based Comp.$37$35$83$89
Change in WC-$30$3-$14$50
Other Non-Cash$160$232$228$16
Operating Cash Flow-$333-$398-$537-$561
Investing Activities
PP&E Inv.-$5-$12-$77-$73
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$24$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$10$22-$24-$64
Investing Cash Flow-$15$10-$124-$137
Financing Activities
Debt Repay.$119$28$135-$13
Stock Issued$0$0$0$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$28-$27-$23-$18
Financing Cash Flow$90$0$112-$31
Forex Effect$10$11$97-$67
Net Chg. in Cash-$249-$377-$451-$796
Supplemental Information
Beg. Cash$1,006$1,383$1,834$2,631
End Cash$757$1,006$1,383$1,834
Free Cash Flow-$349-$413-$614-$634
JW (Cayman) Therapeutics Co. Ltd (JWCTF) Financial Statements & Key Stats | AlphaPilot